noologica.com

What It Is

Noologica is an open-science biotechnology startup from New Zealand, positioned as a provider of digital screening, triage, diagnostic, and monitoring tools for neurodiversity and children’s mental health conditions. Its core offering is not a general-purpose AI assistant, but clinical-oriented digital assessment technology. It is registered with the Health Research Council of New Zealand as an independent research provider and is being used in local and international clinical studies.

Core Capabilities and Use Cases

The technical approach disclosed on the website is as follows: children complete a computer-based reasoning game inspired by Battleships; spatiotemporal metrics and mathematical complexity indicators are collected from task outputs; these are then fed into supervised machine-learning classification models to analyze executive function (EF) patterns. Noologica hypothesizes that different child mental health or neurodiversity conditions exhibit distinguishable EF “signatures.” Typical use cases include screening, assisted diagnosis, clinical triage, and monitoring for ADHD, ASD, and other childhood neurodiversity/mental health conditions. The current test takes about 30-45 minutes, with the goal of reducing the several hours typically required for specialist diagnosis.

Clinical Results and Limitations

Its Phase I/II prospective diagnostic accuracy study covers children aged 5-13 with ADHD combined presentation and typically developing controls. Reference standards include medical history, physical and neurological examinations, the Conners 3rd Edition, and DSM-V. The website states that an independent validation cohort achieved very high accuracy, sensitivity, and specificity, and also mentions preliminary study accuracy above 80%. Replication trials are also underway at research sites in Türkiye, Estonia, and elsewhere. However, these disclosures remain research-stage information and are not yet sufficient to determine how robustly the tool performs across broader disease spectra, different linguistic and cultural contexts, or real-world clinical settings.

Pricing, Integration, and Privacy

The site only emphasizes a “low-cost” vision and does not disclose pricing, free trials, procurement channels, payment methods, API availability, electronic medical record integration, or deployment models. On data privacy, there is also no clear explanation of patient data storage, security compliance, anonymization, or cross-border data processing. For procurement evaluation of a medical AI tool, this is a significant gap.

Pros, Cons, and Who It Is For

The main advantage is its use of objective task data and predictive modeling, aiming to address precision gaps in traditional rating scales and interviews, with a foundation in clinical trials. The downside is the lack of commercialization information and compliance details, making it impossible for users to determine from the official website alone whether it can be directly purchased and deployed. It is more suitable for pediatric, child psychiatry, mental health research, and clinical trial teams to monitor. For ordinary parents or schools seeking direct diagnostic services, the website does not show an available pathway.

Access in China and Alternatives

Access from China, Chinese-language interface availability, and local payment support are unknown. If deployed in China, key areas to assess would include network accessibility, medical device/software compliance, Chinese normative data, local clinical validation, and cross-border data transfer issues. Alternatives include traditional ADHD/ASD clinical assessment workflows, the Conners scale, DSM-V diagnostic processes, and local digital psychological assessment tools.